Market Place
Sourcing Support
Enforcement Report - Week of August 27, 2025
27 Aug 2025 //
FDA
Enforcement Report - Week of August 20, 2025
20 Aug 2025 //
FDA
Hospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine HCL
22 May 2024 //
FDA
Enforcement Report - Week of January 31, 2024
31 Jan 2024 //
FDA
Enforcement Report - Week of January 24, 2024
24 Jan 2024 //
FDA
Enforcement Report - Week of November 15, 2023
15 Nov 2023 //
FDA
Enforcement Report - Week of April 19, 2023
19 Apr 2023 //
FDA
Enforcement Report - Week of February 1, 2023
01 Feb 2023 //
FDA
Enforcement Report - Week of January 11, 2023
11 Jan 2023 //
FDA
Enforcement Report - Week of October 12, 2022
12 Oct 2022 //
FDA
Enforcement Report - Week of September 21, 2022
21 Sep 2022 //
FDA
Enforcement Report - Week of August 3, 2022
03 Aug 2022 //
FDA
Monarch PCM, LLC Receives FDA Warning Letter
29 Jun 2022 //
FDA
Enforcement Report - Week of May 25, 2022
25 May 2022 //
FDA
Pfizer Voluntary Nationwide Recall of Lots of ACCUPRIL
23 Apr 2022 //
FDA
Health Canada Issues Recall Pfizer Canada ULC. Accupril Tabs: Nitrosamine impurity
22 Apr 2022 //
HEALTH CANADA
Enforcement Report - Week of April 13, 2022
13 Apr 2022 //
FDA
Pfizer Canada recalls BP drug on potential cancer-causing impurity
05 Mar 2022 //
HEALTH CANADA
Health Canada Recalls Pfizer`s Accuretic blood pressure tablets due to a nitrosamine impurity
03 Mar 2022 //
HEALTH CANADA
Enforcement Report - Week of December 08, 2021
08 Dec 2021 //
FDA
Pfizer Ltd., Issues Voluntary Recall of Champix film coated tablets 0.5mg, 1mg
14 Oct 2021 //
GOVUK
Enforcement Report - Week of October 6, 2021
06 Oct 2021 //
FDA
Enforcement Report - Week of September 29, 2021
29 Sep 2021 //
FDA
Enforcement Report - Week of August 11, 2021
11 Aug 2021 //
FDA
Enforcement Report- Week of June 9, 2021
09 Jun 2021 //
FDA
Health Canada Issues Recall of Pfizer`s Champix
08 Jun 2021 //
HEALTH CANADA
FDA Issues Form 483 to Hospira Inc. A Pfizer Company
21 Apr 2021 //
FDA
FDA Issues Form 483 to Hospira Inc A Pfizer Company
21 Apr 2021 //
FDA
Enforcement Report - Week of August 12, 2020
12 Aug 2020 //
FDA
Enforcement Report - Week of July 1, 2020
01 Jul 2020 //
FDA
Enforcement Report - Week of June 17, 2020
17 Jun 2020 //
FDA
Pfizer Healthcare India Private Limited Receives FDA Warning Letter
01 Apr 2020 //
FDA
Enforcement Report - Week of March 11, 2020
12 Mar 2020 //
FDA
Enforcement Report - Week of February 19, 2020
20 Feb 2020 //
FDA
Health Canada Issues Recall of Pfizer Canada ULC Docetaxel Injection USP
09 Oct 2019 //
HEALTH CANADA
Health Canada Issues Recall of Pfizer Canada ULC LMD 10% IN DEXTROSE 5%
26 Sep 2019 //
HEALTH CANADA
Enforcement Report - Week of September 18, 2019
18 Sep 2019 //
FDA
Enforcement Report - Week of September 4, 2019
04 Sep 2019 //
FDA
Enforcement Report - Week of July 24, 2019
24 Jul 2019 //
FDA
Health Canada Issues Recall of Pfizer Canada Inc`s Docetaxel Injection USP
03 Jun 2019 //
HEALTH CANADA
Enforcement Report - Week of May 22, 2019
22 May 2019 //
FDA
Enforcement Report - Week of April 10, 2019
10 Apr 2019 //
FDA
Enforcement Report - Week of January 9, 2019
09 Jan 2019 //
FDA
Enforcement Report - Week of December 26, 2018
26 Dec 2018 //
FDA
Hospira (Pfizer) Receives FDA Form 483
06 Dec 2018 //
FDA
Enforcement Report - Week of October 31, 2018
31 Oct 2018 //
FDA
Enforcement Report - Week of October 17, 2018
17 Oct 2018 //
FDA
Enforcement Report - Week of October 10, 2018
10 Oct 2018 //
FDA
Enforcement Report - Week of September 19, 2018
19 Sep 2018 //
FDA
Enforcement Report - Week of September 5, 2018
05 Sep 2018 //
FDA
